The Critical Role of Oxidative Stress in Sarcopenic Obesity
Open accessThe DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index; 62 of the 321 sources its claims cite were checked for support.
Abstract
Sarcopenic obesity (SO) is a combination of obesity and sarcopenia that primarily develops in older people. Patients with SO have high fat mass, low muscle mass, low muscle strength, and low physical function. SO relates to metabolic syndrome and an increased risk of morbimortality. The prevalence of SO varies because of lacking consensus criteria regarding its definition and the methodological difficulty in diagnosing sarcopenia and obesity. SO includes systemic alterations such as insulin resistance, increased proinflammatory cytokines, age‐associated hormonal changes, and decreased physical activity at pathophysiological levels. Interestingly, these alterations are influenced by oxidative stress, which is a critical factor in altering muscle function and the generation of metabolic dysfunctions. Thus, oxidative stress in SO alters muscle mass, the signaling pathways that control it, satellite cell functions, and mitochondrial and endoplasmic reticulum activities. Considering this background, our objectives in this review are to describe SO as a highly prevalent condition and look at the role of oxidative stress in SO pathophysiology.
Overview
CoChat Summary
TL;DR
This review argues that oxidative stress is a central mechanism in sarcopenic obesity (SO) pathophysiology, affecting skeletal muscle, liver, and adipose tissue through mitochondrial dysfunction, endoplasmic reticulum stress, and altered muscle mass control pathways. It also emphasizes that SO is highly prevalent but remains difficult to define and diagnose because of inconsistent criteria.
Key findings
- SO prevalence varies between 2% and 85%, depending on differences in SO definitions, studied populations, and diagnostic criteria/methods for obesity and sarcopenia; there are no internationally standardized criteria for diagnosing SO.
- Oxidative stress in SO is linked to mitochondrial dysfunction, ER stress, and imbalance between anabolic and catabolic muscle mass pathways; ROS activate the ubiquitin-proteasome system (including MuRF1 and atrogin-1), NF-κB, and impair PI3K/Akt/mTOR signaling, while also dysregulating satellite cell function.
- In patients, circulating oxidative stress markers such as GSH, GSSG, MDA, and 4-HNE increase in elderly patients with SO compared with nonsarcopenic nonobese, sarcopenic nonobese, and nonsarcopenic obese patients; systemic oxidative stress is also associated with muscle mass decline in elderly patients with obesity and T2DM.
- Animal-model evidence includes resveratrol preventing SO features via the PKA/LKB1/AMPK pathway, tocotrienols and green tea polyphenols increasing muscle mass, cross-sectional area, and mitochondrial enzyme activity, and Lactobacillus paracasei PS23 attenuating age-related muscle loss with higher mitochondrial function and antioxidant enzymes and lower inflammatory cytokines and oxidative stress.
Methods
- Narrative review describing SO as a highly prevalent condition and examining the role of oxidative stress in its pathophysiology.
- Synthesizes literature on SO definitions, diagnosis, general characteristics, pathophysiology, oxidative stress mechanisms, and redox-dependent mechanisms from animal models and patients.
- No systematic review, meta-analysis, primary data collection, sample size, or formal quantitative analysis is reported.
Limitations
- The paper states that there is no consensus on SO evaluation methods and definitions, so results across investigations are highly variable and difficult to compare; diagnostic methods such as CT, DXA, MRI, and BIA are complex, costly, and less feasible for large-scale research or clinical practice.
- The paper states that there is limited evidence clarifying the mechanisms involved in the redox-dependent effect of SO in human and animal models, and that most animal research tests antiobesity, antiaging, or antioxidant agents rather than directly elucidating how oxidative stress favors SO.
- Evident from the text: as a narrative review, it does not report a systematic search strategy, study quality appraisal, or quantitative synthesis, so its conclusions rely on the cited literature rather than new primary data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
26 Valid · 2 Not valid · 76 Not checked · 15 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Elevated ROS levels activate the UPS, increasing expression of the muscle-specific ubiquitin ligase MuRF1 (Muscle RING-finger protein-1) and atrogin-1.”
§ The Critical Role of Oxidative Stress in Sarcopenic Obesity > 4. Oxidative Stress in Sarcopenic Obesity > 4.3. Imbalance in Muscle Mass Control
What the sources say
- Partly supportedcites [87] Szentesi P. Csernoch L. Dux L. Keller-Pintér A. Changes in redox signaling in the skeletal muscle with aging Oxidative Medicine and Cellular Longevity 2019 2019 12 10.1155/2019/4617801 2-s2.0-85062088513 4617801 30800208 PMC6360032 sourceExperimental — accuracy not yet measured
Section 5, “Age-Related Muscle Loss and Oxidative Stress” (page not provided), says increased ROS activates the ubiquitin-proteasome pathway and that aging is associated with increased MuRF1 and atrogin-1 expression. It does not establish that ROS causes the increase in those ligases; it says further studies are needed to explore oxidative stress’s role in those age-related changes. (LLM, conf=0.87)
- Partly supportedcites [105] Bonaldo P. Sandri M. Cellular and molecular mechanisms of muscle atrophy Disease Models & Mechanisms 2013 6 1 25 39 10.1242/dmm.010389 2-s2.0-84872094183 23268536 PMC3529336 sourceExperimental — accuracy not yet measured
In the IGF1-Akt-FoxO signaling section (page not specified), the paper says that nNOS-induced oxidative stress during muscle disuse enhances FoxO3-mediated transcription of atrogin-1 and MuRF1. The ubiquitin-proteasome system section identifies both as muscle-specific ubiquitin ligases. The paper does not establish the broader claim that elevated ROS activates the ubiquitin-proteasome system as a whole. (LLM, conf=0.84)
- Partly supportedcites [108] Gomes M. J. Martinez P. F. Pagan L. U. Skeletal muscle aging: influence of oxidative stress and physical exercise Oncotarget 2017 8 12 20428 20440 10.18632/oncotarget.14670 2-s2.0-85015268417 28099900 PMC5386774 sourceExperimental — accuracy not yet measured
The “Reactive Oxygen Species and Skeletal Muscle Ageing” section (page not provided) states that increased ROS activates the ubiquitin-proteasome system. It does not say that ROS increases MuRF1 or atrogin-1 expression; those ligases appear only in a reference title about IGF-I suppressing their expression. (LLM, conf=0.87)
- Disputedcites [111] Altun M. Besche H. C. Overkleeft H. S. Muscle Wasting in Aged, Sarcopenic Rats Is Associated with Enhanced Activity of the Ubiquitin Proteasome Pathway The Journal of Biological Chemistry 2010 285 51 39597 39608 10.1074/jbc.M110.129718 2-s2.0-78650046347 20940294 PMC3000941 sourceExperimental — accuracy not yet measured
In “The UPS in Muscles of Aged Rats” (p. 8), the paper reports that MuRF1 and atrogin-1 expression was not higher in aged sarcopenic rats; atrogin-1 protein decreased, although MuRF1 protein increased. Its discussion (p. 11) suggests that enhanced UPS capacity may respond to damaged proteins, but does not establish that ROS activates the UPS or increases expression of both ligases. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [112] Baumann C. W. Kwak D. Liu H. M. Thompson L. V. Age-induced oxidative stress: how does it influence skeletal muscle quantity and quality? Journal of applied physiology (Bethesda, Md.: 1985) 2016 121 5 1047 1052 10.1152/japplphysiol.00321.2016 2-s2.0-84994530411 27197856 PMC5142250 sourceExperimental — accuracy not yet measured
The ‘ROS/RNS and Muscle Quantity’ section (p. 5) says ROS production can upregulate components of the ubiquitin-proteasome system and promote protein breakdown. It does not identify MuRF1 or atrogin-1 as components whose expression increases, and it describes the mechanism in old muscle as uncertain rather than established. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Aging comes with is a decrease in anabolic hormones such as testosterone and GH.”
§ The Critical Role of Oxidative Stress in Sarcopenic Obesity > 3. Pathophysiology of Sarcopenic Obesity > 3.3. Hormonal Changes
What the sources say
- Supportedcites [31] Sakuma K. Yamaguchi A. Sarcopenic obesity and endocrinal adaptation with age International Journal of Endocrinology 2013 2013 12 10.1155/2013/204164 2-s2.0-84877275009 204164 23690769 PMC3639625 source
Section 3.1, “GH and Testosterone,” states that testosterone levels decrease with age and that circulating growth hormone (GH) levels decline progressively after age 30. It also describes these as age-related decreases in anabolic hormones. (LLM, conf=0.94)
- Supportedcites [41] Wang J. Leung K.-S. Chow S. K.-H. Cheung W.-H. Inflammation and age-associated skeletal muscle deterioration (sarcopaenia) Journal of orthopaedic translation 2017 10 94 101 10.1016/j.jot.2017.05.006 2-s2.0-85029079770 29662761 PMC5822997 source
The Pathogenesis of Sarcopaenia section states that serum concentrations of testosterone and growth hormone decline in ageing individuals and identifies them as anabolic hormones. (LLM, conf=0.95)
- Not checked yetcites [51] Dam P. Smid H. de Vries W. Reduction of free fatty acids by acipimox enhances the growth hormone (GH) responses to GH-releasing peptide 2 in elderly men The Journal of Clinical Endocrinology and Metabolism 2000 85 12 4706 4711 10.1210/jcem.85.12.7087 11134132 source
- Not checked yetcites [52] Allan C. A. Strauss B. J. G. McLachlan R. I. Body composition, metabolic syndrome and testosterone in ageing men International Journal of Impotence Research 2007 19 5 448 457 10.1038/sj.ijir.3901552 2-s2.0-34548458613 17554396 source
- Not checked yetcites [53] Waters D. L. Qualls C. R. Dorin R. I. Veldhuis J. D. Baumgartner R. N. Altered growth hormone, cortisol, and leptin secretion in healthy elderly persons with sarcopenia and mixed body composition phenotypes The Journals of Gerontology: Series A 2008 63 5 536 541 10.1093/gerona/63.5.536 2-s2.0-47049125873 18511760 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As mentioned above, myosteatosis has been associated with aging, limiting functional activities due to decreased muscle mass and strength [71].”
§ The Critical Role of Oxidative Stress in Sarcopenic Obesity > 3. Pathophysiology of Sarcopenic Obesity > 3.4. Decrease of Physical Activity
What the sources say
- Partly supportedcites [71] Zoico E. Corzato F. Bambace C. Myosteatosis and myofibrosis: relationship with aging, inflammation and insulin resistance Archives of Gerontology and Geriatrics 2013 57 3 411 416 10.1016/j.archger.2013.06.001 2-s2.0-84881666792 23809667 PMC5278642 sourceExperimental — accuracy not yet measured
The INTRODUCTION (p. 1) supports the two core elements: MS 'increases with age and adiposity' and is 'strongly related to... poorer strength and scores on performance tests (Visser 2005), as well as incident mobility disability'. However, the causal chain the claim attributes — functional limitation 'due to decreased muscle mass and strength' — is not what this paper says: the mass/function-loss route is credited to the sarcopenia literature (Janssen 2010, Glass 2010), and the DISCUSSION (p. 1) instead frames MS as a qualitative change operating where there is a 'mismatch between the age-related decrease in muscle mass and in muscle power'. The paper's own data (RESULTS/METHODS, p. 1-2: 16 healthy elderly men, none with ADL deficit, no strength or performance measures) report associations with adiposity, leptin, insulin resistance and inflammation, not with functional activities. (LLM, conf=0.72)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Protein synthesis is reduced under Os conditions [107, 108]”
§ The Critical Role of Oxidative Stress in Sarcopenic Obesity > 4. Oxidative Stress in Sarcopenic Obesity > 4.3. Imbalance in Muscle Mass Control
What the sources say
- Could not verifycites [107] Ali S. Garcia J. M. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review Gerontology 2014 60 4 294 305 10.1159/000356760 2-s2.0-84903538743 24731978 PMC4112511 sourceExperimental — accuracy not yet measured
The sections on mechanisms regulating skeletal muscle mass and sarcopenia pathophysiology discuss protein synthesis and report that it decreases with aging. Neither those passages nor searches for oxidative stress and reactive oxygen species link oxidative stress to reduced protein synthesis. No page numbers were provided in our copy. (LLM, conf=0.72)
- Partly supportedcites [108] Gomes M. J. Martinez P. F. Pagan L. U. Skeletal muscle aging: influence of oxidative stress and physical exercise Oncotarget 2017 8 12 20428 20440 10.18632/oncotarget.14670 2-s2.0-85015268417 28099900 PMC5386774 sourceExperimental — accuracy not yet measured
The ‘Etiology and intracellular pathways involved in aging-associated muscle changes’ section says muscle protein synthesis is blunted in aging, attributing this to changes in anabolic signaling. The ‘Reactive oxygen species and skeletal muscle ageing’ section discusses oxidative stress and ROS-related protein breakdown, but does not say oxidative stress reduces protein synthesis. The claimed condition is therefore not supported by this source. (LLM, conf=0.80)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ROS also activates muscle proteases such as caspases and calpains, leading to protein breakdown [87, 105, 108, 111, 112].”
§ The Critical Role of Oxidative Stress in Sarcopenic Obesity > 4. Oxidative Stress in Sarcopenic Obesity > 4.3. Imbalance in Muscle Mass Control
What the sources say
- Partly supportedcites [87] Szentesi P. Csernoch L. Dux L. Keller-Pintér A. Changes in redox signaling in the skeletal muscle with aging Oxidative Medicine and Cellular Longevity 2019 2019 12 10.1155/2019/4617801 2-s2.0-85062088513 4617801 30800208 PMC6360032 sourceExperimental — accuracy not yet measured
Section 5 (page unavailable) says ROS accumulation can increase proteolysis and activate the ubiquitin-proteasome pathway. It also reports increased calpain activity with aging, but says the role of oxidative stress in that change needs further study; it does not establish that ROS activates calpains or caspases. (LLM, conf=0.88)
- Partly supportedcites [105] Bonaldo P. Sandri M. Cellular and molecular mechanisms of muscle atrophy Disease Models & Mechanisms 2013 6 1 25 39 10.1242/dmm.010389 2-s2.0-84872094183 23268536 PMC3529336 sourceExperimental — accuracy not yet measured
The IGF1-Akt-FoxO signaling section links oxidative stress to FoxO-mediated muscle loss, and the autophagy-lysosome section describes oxidative-stress-induced muscle atrophy through autophagy. Neither passage says that ROS activates caspases or calpains; searches for those proteases found no supporting passage in our copy. (LLM, conf=0.86)
- Supportedcites [108] Gomes M. J. Martinez P. F. Pagan L. U. Skeletal muscle aging: influence of oxidative stress and physical exercise Oncotarget 2017 8 12 20428 20440 10.18632/oncotarget.14670 2-s2.0-85015268417 28099900 PMC5386774 source
The section “Reactive Oxygen Species and Skeletal Muscle Ageing” states that increased ROS production activates muscle proteases, including caspases and calpains, leading to protein breakdown. This directly supports the attributed claim. (LLM, conf=0.95)
- Could not verifycites [111] Altun M. Besche H. C. Overkleeft H. S. Muscle Wasting in Aged, Sarcopenic Rats Is Associated with Enhanced Activity of the Ubiquitin Proteasome Pathway The Journal of Biological Chemistry 2010 285 51 39597 39608 10.1074/jbc.M110.129718 2-s2.0-78650046347 20940294 PMC3000941 sourceExperimental — accuracy not yet measured
The discussion of damaged proteins (pp. 10–11) links reactive oxygen species to oxidative damage and discusses degradation through the ubiquitin–proteasome system. It does not say that ROS activate caspases or calpains to break down muscle proteins. Searches for ROS-driven activation of those proteases found no supporting passage; the paper’s reference to a “caspase-like” site concerns the proteasome, not caspases. (LLM, conf=0.75)
- Partly supportedcites [112] Baumann C. W. Kwak D. Liu H. M. Thompson L. V. Age-induced oxidative stress: how does it influence skeletal muscle quantity and quality? Journal of applied physiology (Bethesda, Md.: 1985) 2016 121 5 1047 1052 10.1152/japplphysiol.00321.2016 2-s2.0-84994530411 27197856 PMC5142250 sourceExperimental — accuracy not yet measured
The “ROS/RNS and Muscle Quantity” section (p. 5) says ROS production can promote protein breakdown through activation of muscle proteases, including caspases and calpains. The citing sentence presents this as an established effect, whereas the review describes it as a possible mechanism and says its role in old muscle remains unclear. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
31 more claims · 4 with their cited sources checked
Create a free account to see all 119 claims and to verify the 259 references still open.
- Probably not a substantial claim. 16
- It may state two separate claims as one. 78
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Oxidative stress can also lead to ER stress, which is characterized by unfolded protein response (UPR) causing dysfunction of proteasomal degradation and autophagy, which reduces protein levels and causes an imbalance in calcium homeostasis that altogether favor a decrease in muscle mass (30, 31).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ROS alter mitochondrial function and mass, increase mitochondrial DNA damage, reduce ATP synthesis, and elicit apoptotic pathway activity, which altogether, lead to a reduction in muscle mass.”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“The pathophysiology of this condition involves a complex interplay between muscle, adipose tissue, hormonal changes, inflammation, oxidative stress and lifestyle factors, among others.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [50]
In the citing paper
“Oxidative stress adversely impacts muscle health through muscle protein breakdown60, muscle inflammation61, impaired muscle regeneration62, mitochondrial dysfunction63 and insulin resistance50.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [50]
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 2×
“It is classified as primary (associated with aging) or secondary (associated with limitedmobility, malnutrition, or chronic diseases, such as obesity) [26, 27].”
BackgroundThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Oxidative Stress and Antioxidant Defense
Birben, E., Sahiner, U. M., Sackesen, C., Erzurum, S., & Kalayci, O. (2012) · World Allergy Organization Journal · doi:10.1097/wox.0b013e3182439613 · Cited by 4,935 · cited 1×
“Exogenous antioxidants include ascorbic acid (vitamin C), α-tocopherol (vitamin E), and phenolic antioxidants (such as resveratrol, phenolic acids, flavonoids, selenium, zinc, and acetylcysteine) [75, 80, 81].”
BackgroundOxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979 · cited 6×
“In this regard, aging causes the loss of type II muscle fibers more than type I, probably because type II fibers have a low mitochondrial quantity, making them more susceptible to degradation and loss of muscle mass [75, 87, 88].”
BackgroundInfluentialSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Goodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083
Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases
Phaniendra, A., Jestadi, D. B., & Periyasamy, L. (2015) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-014-0446-0 · Cited by 2,886 · cited 1×
“In contrast, exogenous sources include air and water pollution, tobacco, alcohol, heavy metals, drugs, industrial solvents, cooking pollutants, and radiation [75, 78, 79].”
BackgroundThe role of antioxidants in the chemistry of oxidative stress: A review
Pisoschi, A. M., & Pop, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.040 · Cited by 2,806 · cited 1×
“Exogenous antioxidants include ascorbic acid (vitamin C), α-tocopherol (vitamin E), and phenolic antioxidants (such as resveratrol, phenolic acids, flavonoids, selenium, zinc, and acetylcysteine) [75, 80, 81].”
BackgroundEndoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802 · cited 2×
“The ER stress and Os in these conditions are related to the “nutrient-sensing” functions of ER, which affect metabolic response at the endocrine and systemic levels [91].”
BackgroundBodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525 · cited 1×
“Also, adipocytes from obese and insulinresistant subjects (humans and mice) present elevated lipid storage, lipogenesis, and adipokine synthesis, all of which induce ER stress and Os [83, 91, 96].”
BackgroundFeldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis
Brack, A. S., Conboy, M. J., Roy, S., Lee, M., Kuo, C. J., Keller, C., & Rando, T. A. (2007) · Science · doi:10.1126/science.1144090 · Cited by 1,564 · cited 1×
“It is characterized by replacing skeletal muscle with fibrous connective tissue and impaired regenerative muscle capacity, decreasing muscle mass and functionality [71, 72].”
BackgroundSarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382 · cited 1×
“Similarly, there is a need for advances in reaching a consensus in the methodology for the SO diagnosis that can be applicable in different populations, ideally used in clinical practice, and feasible for use in long-standing studies [3, 7, 12, 16, 37, 48, 152, 153].”
BackgroundCellular and molecular mechanisms of muscle atrophy
Bonaldo, P., & Sandri, M. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010389 · Cited by 1,284 · cited 1×
“ROS also activates muscle proteases such as caspases and calpains, leading to protein breakdown [87, 105, 108, 111, 112].”
BackgroundMolecular inflammation: Underpinnings of aging and age-related diseases
Chung, H. Y., Cesari, M., Anton, S., Marzetti, E., Giovannini, S., Seo, A. Y., Carter, C., Yu, B. P., & Leeuwenburgh, C. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2008.07.002 · Cited by 1,203 · cited 1×
“These conditions increase catabolic pathway activity and decrease anabolic pathway activity in skeletal muscle, promoting the loss of muscle mass and strength [76, 114].”
BackgroundLim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164 · cited 2×
“Furthermore, in aging, increased intramuscular (myosteatosis) and intrahepatic (liver steatosis) fat deposits induce IR [31, 32].”
BackgroundNotch-Mediated Restoration of Regenerative Potential to Aged Muscle
Conboy, I. M., Conboy, M. J., Smythe, G. M., & Rando, T. A. (2003) · Science · doi:10.1126/science.1087573 · Cited by 1,121
Body Composition in Healthy Aging
BAUMGARTNER, R. N. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06498.x · Cited by 1,078
Sarcopenic obesity: definition, cause and consequences
Stenholm, S., Harris, T. B., Rantanen, T., Visser, M., Kritchevsky, S. B., & Ferrucci, L. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328312c37d · Cited by 1,070
The effect of obesity on lung function
Dixon, A. E., & Peters, U. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1506331 · Cited by 889
Kregel, K. C., & Zhang, H. J. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00327.2006 · Cited by 883 · cited 1×
“Thus, Os could play a fundamental role in losing the muscle mass that characterizes SO and promote IR [76, 92, 103].”
BackgroundKalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882 · cited 1×
“Indeed, they favor IR and low anabolic activity in skeletal muscle [40, 109].”
BackgroundAsakura, A., Rudnicki, M. A., & Komaki, M. (2001) · Differentiation · doi:10.1046/j.1432-0436.2001.680412.x · Cited by 839
Clinical definition of sarcopenia
Santilli, V (2014) · Clinical Cases in Mineral and Bone Metabolism · doi:10.11138/ccmbm/2014.11.3.177 · Cited by 710
Protein breakdown in muscle wasting: Role of autophagy-lysosome and ubiquitin-proteasome
Sandri, M. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.04.023 · Cited by 689
Oxidative Stress, Molecular Inflammation and Sarcopenia
Meng, S.-J., & Yu, L.-J. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11041509 · Cited by 637 · cited 3×
“NF-κB activation induces inflammation and IR, favoring catabolic activity, and decreases anabolic pathways in skeletal muscle [76, 83].”
BackgroundMitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials
Marzetti, E., Calvani, R., Cesari, M., Buford, T. W., Lorenzi, M., Behnke, B. J., & Leeuwenburgh, C. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.06.024 · Cited by 627 · cited 2×
“TNF-α is a proinflammatory cytokine that increases in aging and obesity, promotes protein degradation, decreases protein synthesis, and inhibits myogenic differentiation [14, 45].”
BackgroundSarcopenic obesity and inflammation in the InCHIANTI study
Schrager, M. A., Metter, E. J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., & Ferrucci, L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00627.2006 · Cited by 594 · cited 1×
“This effect could be associated with higher levels of “geriatric cytokines,” such as IL-6 and CRP, which decrease muscle mass and strength [14, 38].”
BackgroundBernet, J. D., Doles, J. D., Hall, J. K., Kelly Tanaka, K., Carter, T. A., & Olwin, B. B. (2014) · Nature Medicine · doi:10.1038/nm.3465 · Cited by 573
Coordination of ER and oxidative stress signaling: The PERK/Nrf2 signaling pathway
Cullinan, S. B., & Diehl, J. A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.09.018 · Cited by 554
Lipid accumulation in non-adipose tissue and lipotoxicity
van Herpen, N. A., & Schrauwen-Hinderling, V. B. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.049 · Cited by 500 · cited 9×
“The obesity diagnosis is marked by difficulties, particularly in relation to BMI.”
MethodInfluentialFuente, M., & Miquel, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789058110 · Cited by 496 · cited 1×
“The oxidation-inflammatory theory of aging or “oxiinflamm-aging” proposes that, during aging, chronic Os impairs the immune system, induces an inflammatory state, and creates a vicious circle of Os-inflammation-Os that damages structures, tissues, and organs [75, 82].”
BackgroundSatellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly
Verdijk, L. B., Koopman, R., Schaart, G., Meijer, K., Savelberg, H. H. C. M., & van Loon, L. J. C. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00278.2006 · Cited by 489 · cited 1×
“The reduction in these cells has been explicitly shown in type II fibers more than in type I during aging [87, 117].”
BackgroundChanges in Body Composition in Women over Six Years at Midlife: Ovarian and Chronological Aging
Sowers, M., Zheng, H., Tomey, K., Karvonen-Gutierrez, C., Jannausch, M., Li, X., Yosef, M., & Symons, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1393 · Cited by 470 · cited 1×
“These effects could be mitigated with hormone replacement therapy [37, 59, 60].”
BackgroundRolland, Y., Lauwers-Cances, V., Cristini, C., van Kan, G. A., Janssen, I., Morley, J. E., & Vellas, B. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26950 · Cited by 465
Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms and Therapeutic Options - A Mini-Review
Ali, S., & Garcia, J. M. (2014) · Gerontology · doi:10.1159/000356760 · Cited by 462 · cited 3×
“Also, physical inactivity (a characteristic of obesity and sarcopenia in aging) indirectly inhibits the mTOR pathway through Fox-O stimulation [107, 108].”
BackgroundCao, L., & Morley, J. E. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.06.001 · Cited by 424
STAT3 signaling controls satellite cell expansion and skeletal muscle repair
Tierney, M. T., Aydogdu, T., Sala, D., Malecova, B., Gatto, S., Puri, P. L., Latella, L., & Sacco, A. (2014) · Nature Medicine · doi:10.1038/nm.3656 · Cited by 401
Hermans, G., Wilmer, A., Meersseman, W., Milants, I., Wouters, P. J., Bobbaers, H., Bruyninckx, F., & Van den Berghe, G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-665oc · Cited by 368
Sarcopenia and sarcopenic obesity
Choi, K. M. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.193 · Cited by 344
Reduced physical activity increases intermuscular adipose tissue in healthy young adults
Manini, T. M., Clark, B. C., Nalls, M. A., Goodpaster, B. H., Ploutz-Snyder, L. L., & Harris, T. B. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.2.377 · Cited by 332 · cited 1×
“As mentioned earlier, physical inactivity and obesity increase the level of lipid circulation and myosteatosis in skeletal muscle, contributing to a decrease in muscle mass and strength and favoring sarcopenia and physical disabilities [14, 22, 66].”
BackgroundInflammation and the Metabolic Syndrome: The Tissue-Specific Functions of NF-κB
Catrysse, L., & van Loo, G. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.01.006 · Cited by 329 · cited 4×
“NF-κB activation induces inflammation and IR, favoring catabolic activity, and decreases anabolic pathways in skeletal muscle [76, 83].”
BackgroundInfluentialKim, Y.-S., Lee, Y., Chung, Y.-S., Lee, D.-J., Joo, N.-S., Hong, D., Song, G. E., Kim, H.-J., Choi, Y. J., & Kim, K.-M. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls071 · Cited by 327
Obesity and weight management in the elderly
Han, T. S., Tajar, A., & Lean, M. E. J. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr002 · Cited by 327
Biochemical basis and metabolic interplay of redox regulation
Zhang, L., Wang, X., Cueto, R., Effi, C., Zhang, Y., Tan, H., Qin, X., Ji, Y., Yang, X., & Wang, H. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101284 · Cited by 308
Skeletal muscle aging: influence of oxidative stress and physical exercise
Gomes, M. J., Martinez, P. F., Pagan, L. U., Damatto, R. L., Mariano Cezar, M. D., Ruiz Lima, A. R., Okoshi, K., & Okoshi, M. P. (2017) · Oncotarget · doi:10.18632/oncotarget.14670 · Cited by 285 · cited 4×
“Also, physical inactivity (a characteristic of obesity and sarcopenia in aging) indirectly inhibits the mTOR pathway through Fox-O stimulation [107, 108].”
BackgroundInfluentialChung, J.-Y., Kang, H.-T., Lee, D.-C., Lee, H.-R., & Lee, Y.-J. (2013) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2012.09.007 · Cited by 283
Mechanism of increased risk of insulin resistance in aging skeletal muscle
Shou, J., Chen, P.-J., & Xiao, W.-H. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-0523-x · Cited by 283
Sarcopenia: Effects on Body Composition and Function
Roubenoff, R. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.11.m1012 · Cited by 282
Tian, S., & Xu, Y. (2016) · Geriatrics & Gerontology International · doi:10.1111/ggi.12579 · Cited by 274
TNF-α impairs heart and skeletal muscle protein synthesis by altering translation initiation
Lang, C. H., Frost, R. A., Nairn, A. C., MacLean, D. A., & Vary, T. C. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00366.2001 · Cited by 265
Sarcopenic obesity: time to meet the challenge
Barazzoni, R., Bischoff, S. C., Boirie, Y., Busetto, L., Cederholm, T., Dicker, D., Toplak, H., Van Gossum, A., Yumuk, V., & Vettor, R. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.04.018 · Cited by 260
Hsu, K.-J., Liao, C.-D., Tsai, M.-W., & Chen, C.-N. (2019) · Nutrients · doi:10.3390/nu11092163 · Cited by 258
Fat mass changes during menopause: a metaanalysis
Ambikairajah, A., Walsh, E., Tabatabaei-Jafari, H., & Cherbuin, N. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.04.023 · Cited by 255 · cited 1×
“These effects could be mitigated with hormone replacement therapy [37, 59, 60].”
BackgroundChronic Pain and Obesity in Elderly People: Results from the Einstein Aging Study
McCarthy, L. H., Bigal, M. E., Katz, M., Derby, C., & Lipton, R. B. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.02089.x · Cited by 251
Alibegovic, A. C., Sonne, M. P., Højbjerre, L., Bork-Jensen, J., Jacobsen, S., Nilsson, E., Færch, K., Hiscock, N., Mortensen, B., Friedrichsen, M., et al. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00590.2009 · Cited by 247 · cited 1×
“Furthermore, physical inactivity, a feature typically observed in aging and obesity, favors ER stress and UPR overactivation, inducing Os [93, 102].”
BackgroundPhilippou, Α., Halapas, A., Maridaki, M. D., & Koutsilieris, M. (2007) · PubMed · Cited by 233
Aging and Regional Differences in Fat Cell Progenitors – A Mini-Review
Sepe, A., Tchkonia, T., Thomou, T., Zamboni, M., & Kirkland, J. L. (2011) · Gerontology · doi:10.1159/000279755 · Cited by 232
Aging of the musculoskeletal system: How the loss of estrogen impacts muscle strength
Collins, B. C., Laakkonen, E. K., & Lowe, D. A. (2019) · Bone · doi:10.1016/j.bone.2019.03.033 · Cited by 227 · cited 1×
“Besides, sarcopenia increases hospitalization, osteoarthritis, osteoporosis, and the risk of institutionalization [30].”
BackgroundAltun, M., Besche, H. C., Overkleeft, H. S., Piccirillo, R., Edelmann, M. J., Kessler, B. M., Goldberg, A. L., & Ulfhake, B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.129718 · Cited by 226 · cited 1×
“ROS also activates muscle proteases such as caspases and calpains, leading to protein breakdown [87, 105, 108, 111, 112].”
BackgroundRole of visceral adipose tissue in aging
Huffman, D. M., & Barzilai, N. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.01.008 · Cited by 220
Polyzos, S. A., & Margioris, A. N. (2018) · Hormones · doi:10.1007/s42000-018-0049-x · Cited by 212 · cited 2×
“They generally have a sedentary lifestyle and engage in harmful habits such as tobacco and alcohol consumption and a high-fat and/or carbohydrate diet [3].”
BackgroundIliodromiti, S., Celis-Morales, C. A., Lyall, D. M., Anderson, J., Gray, S. R., Mackay, D. F., Nelson, S. M., Welsh, P., Pell, J. P., Gill, J. M. R., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy057 · Cited by 208
Expression and function of myostatin in obesity, diabetes, and exercise adaptation
ALLEN, D. L., HITTEL, D. S., & MCPHERRON, A. C. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182178bb4 · Cited by 207 · cited 1×
“Thus, it could favor the loss of skeletal muscle in SO [14, 61, 62].”
BackgroundSarcopenia: Clinical evaluation, biological markers and other evaluation tools
Pahor, M., Manini, T., & Cesari, M. (2009) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0204-9 · Cited by 200
Sarcopenic obesity is closely associated with metabolic syndrome
Lu, C.-W., Yang, K.-C., Chang, H.-H., Lee, L.-T., Chen, C.-Y., & Huang, K.-C. (2013) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.02.003 · Cited by 198
Clinical detection of sarcopenic obesity by bioelectrical impedance analysis
Heber, D., Ingles, S., Ashley, J., Maxwell, M., Lyons, R., & Elashoff, R. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.3.472s · Cited by 198
Obesity in Older Adults: A Systematic Review of the Evidence for Diagnosis and Treatment
McTigue, K. M., Hess, R., & Ziouras, J. (2006) · Obesity · doi:10.1038/oby.2006.171 · Cited by 196
Myostatin and Sarcopenia: Opportunities and Challenges - A Mini-Review
White, T. A., & LeBrasseur, N. K. (2014) · Gerontology · doi:10.1159/000356740 · Cited by 191 · cited 1×
“Thus, it could favor the loss of skeletal muscle in SO [14, 61, 62].”
BackgroundMitochondria, Muscle Health, and Exercise with Advancing Age
Carter, H. N., Chen, C. C. W., & Hood, D. A. (2015) · Physiology · doi:10.1152/physiol.00039.2014 · Cited by 191 · cited 2×
“Moreover, muscle abilities for removing dysfunctional mitochondria become deficient, perpetuating Os [75, 84, 85].”
BackgroundSarcopenic obesity and endocrinal adaptation with age
Sakuma, K., & Yamaguchi, A. (2013) · International Journal of Endocrinology · doi:10.1155/2013/204164 · Cited by 189 · cited 6×
“Also, in aging, there are decreased rest metabolic rates (4% per decade after the age of 50 years), reduced motor neurons, and skeletal muscle metabolic adaptations, which could also favor obesity and loss of muscle mass [14, 31, 37, 73, 74].”
BackgroundInfluentialLevine, M. E., & Crimmins, E. M. (2012) · Obesity · doi:10.1038/oby.2012.20 · Cited by 186 · cited 1×
“It increases in the elderly and is related to sarcopenia and SO [41, 42].”
BackgroundIntramuscular lipid metabolism, insulin action, and obesity
Consitt, L. A., Bell, J. A., & Houmard, J. A. (2009) · IUBMB Life · doi:10.1002/iub.142 · Cited by 180
Serum markers of inflammation and oxidative stress in sarcopenia
Can, B., Kara, O., Kizilarslanoglu, M. C., Arik, G., Aycicek, G. S., Sumer, F., Civelek, R., Demirtas, C., & Ulger, Z. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0626-2 · Cited by 176 · cited 1×
“Furthermore, a study identified biomarkers of inflammation and Os, such as serum adiponectin, the erythrocyte sedimentation rate (ESR), and CRP levels, as being associated with sarcopenia [150].”
BackgroundSarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives
Koliaki, C., Liatis, S., Dalamaga, M., & Kokkinos, A. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00359-9 · Cited by 176 · cited 2×
“As such, it is difficult to reach a consensus due to the multiple methods of evaluation for each condition, the use of some imprecise techniques (such as body mass index (BMI)), and the existence of different cut-off points for some values according to the population to be evaluated [12] (see Table 1).”
BackgroundFrailty and muscle metabolism dysregulation in the elderly
Evans, W. J., Paolisso, G., Abbatecola, A. M., Corsonello, A., Bustacchini, S., Strollo, F., & Lattanzio, F. (2010) · Biogerontology · doi:10.1007/s10522-010-9297-0 · Cited by 173
Inflammation and age-associated skeletal muscle deterioration (sarcopaenia)
Wang, J., Leung, K.-S., Chow, S. K.-H., & Cheung, W.-H. (2017) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2017.05.006 · Cited by 173 · cited 1×
“It increases in the elderly and is related to sarcopenia and SO [41, 42].”
BackgroundMarzetti, E., Wohlgemuth, S. E., Lees, H. A., Chung, H.-Y., Giovannini, S., & Leeuwenburgh, C. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.05.005 · Cited by 172
Age-induced oxidative stress: how does it influence skeletal muscle quantity and quality?
Baumann, C. W., Kwak, D., Liu, H. M., & Thompson, L. V. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00321.2016 · Cited by 169 · cited 1×
“ROS also activates muscle proteases such as caspases and calpains, leading to protein breakdown [87, 105, 108, 111, 112].”
BackgroundHuang, Y., Zhu, X., Chen, K., Lang, H., Zhang, Y., Hou, P., Ran, L., Zhou, M., Zheng, J., Yi, L., et al. (2019) · Aging · doi:10.18632/aging.101910 · Cited by 167 · cited 1×
“The preventive mechanism involved the PKA/LKB1/AMPK pathway [131].”
BackgroundRenin‐Angiotensin System: An Old Player with Novel Functions in Skeletal Muscle
Cabello‐Verrugio, C., Morales, M. G., Rivera, J. C., Cabrera, D., & Simon, F. (2015) · Medicinal Research Reviews · doi:10.1002/med.21343 · Cited by 165 · cited 1×
“Angiotensin 1-7 (Ang-(1-7)) is a small endogenous peptide that belongs to the renin-angiotensin system [137].”
BackgroundSelf-citationFreiberger, E., Goisser, S., Porzel, S., Volkert, D., Kemmler, W., Sieber, C., & Bollheimer, C. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s82454 · Cited by 162
Apoptosis and aging: increased resistance to apoptosis enhances the aging process
Salminen, A., Ojala, J., & Kaarniranta, K. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0597-y · Cited by 158
Bellanti, F., Romano, A. D., Lo Buglio, A., Castriotta, V., Guglielmi, G., Greco, A., Serviddio, G., & Vendemiale, G. (2018) · Maturitas · doi:10.1016/j.maturitas.2017.12.002 · Cited by 158 · cited 1×
“These findings confirm that Os is related to SO [148].”
BackgroundSarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
Kob, R., Bollheimer, L. C., Bertsch, T., Fellner, C., Djukic, M., Sieber, C. C., & Fischer, B. E. (2015) · Biogerontology · doi:10.1007/s10522-014-9539-7 · Cited by 151 · cited 6×
“Also, in aging, there are decreased rest metabolic rates (4% per decade after the age of 50 years), reduced motor neurons, and skeletal muscle metabolic adaptations, which could also favor obesity and loss of muscle mass [14, 31, 37, 73, 74].”
BackgroundInfluentialRegenerative decline of stem cells in sarcopenia
Sousa-Victor, P., & Muñoz-Cánoves, P. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.02.002 · Cited by 147
Baker, L. D., Barsness, S. M., Borson, S., Merriam, G. R., Friedman, S. D., Craft, S., & Vitiello, M. V. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1970 · Cited by 138 · cited 1×
“In obesity, Os also inhibits mitochondrial function, resulting in Lptx, which impairs insulin signaling (a powerful anabolic signal), promotes high catabolism (which induces muscle mass loss), and leads to IR and inflammation [40, 89].”
BackgroundKeller, K. (2018) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-018-0618-2 · Cited by 136
Reactive Oxygen and Nitrogen Species: Impact on Endothelial Dysfunction
Salisbury, D., & Bronas, U. (2015) · Nursing Research · doi:10.1097/nnr.0000000000000068 · Cited by 134 · cited 1×
“In contrast, exogenous sources include air and water pollution, tobacco, alcohol, heavy metals, drugs, industrial solvents, cooking pollutants, and radiation [75, 78, 79].”
BackgroundMitochondrial ROS regulate oxidative damage and mitophagy but not age-related muscle fiber atrophy
Sakellariou, G. K., Pearson, T., Lightfoot, A. P., Nye, G. A., Wells, N., Giakoumaki, I. I., Vasilaki, A., Griffiths, R. D., Jackson, M. J., & McArdle, A. (2016) · Scientific Reports · doi:10.1038/srep33944 · Cited by 133 · cited 1×
“In this regard, aging causes the loss of type II muscle fibers more than type I, probably because type II fibers have a low mitochondrial quantity, making them more susceptible to degradation and loss of muscle mass [75, 87, 88].”
BackgroundHormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132
Ageing and the regulation of protein synthesis: a balancing act?
Tavernarakis, N. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.02.004 · Cited by 129
Sarcopenia: Molecular Pathways and Potential Targets for Intervention
Pascual-Fernández, J., Fernández-Montero, A., Córdova-Martínez, A., Pastor, D., Martínez-Rodríguez, A., & Roche, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228844 · Cited by 125
Wang, H., Hai, S., Cao, L., Zhou, J., Liu, P., & Dong, B.-R. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0386-z · Cited by 124
Sarcopenic obesity as an independent risk factor of hypertension
Park, S. H., Park, J. H., Song, P. S., Kim, D. K., Kim, K. H., Seol, S. H., Kim, H. K., Jang, H. J., Lee, J. G., Park, H. Y., et al. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.06.002 · Cited by 118
Myosteatosis and myofibrosis: Relationship with aging, inflammation and insulin resistance
Zoico, E., Corzato, F., Bambace, C., Rossi, A. P., Micciolo, R., Cinti, S., Harris, T. B., & Zamboni, M. (2013) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2013.06.001 · Cited by 118 · cited 2×
“It is characterized by replacing skeletal muscle with fibrous connective tissue and impaired regenerative muscle capacity, decreasing muscle mass and functionality [71, 72].”
BackgroundChen, L.-H., Huang, S.-Y., Huang, K.-C., Hsu, C.-C., Yang, K.-C., Li, L.-A., Chan, C.-H., & Huang, H.-Y. (2019) · Aging · doi:10.18632/aging.101782 · Cited by 117 · cited 1×
“Mechanistically, treatment with LPPS23 produced a higher mitochondrial function, antioxidant enzymes, and lower inflammatory cytokines and Os [133].”
BackgroundSarcopenia and sarcopenic obesity
Choi, K. M. (2013) · Endocrinology and Metabolism · doi:10.3803/enm.2013.28.2.86 · Cited by 113
Waters, D. L., Qualls, C. R., Dorin, R. I., Veldhuis, J. D., & Baumgartner, R. N. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.5.536 · Cited by 112
Aging and regulated protein degradation: who has the UPPer hand?
Vernace, V. A., Schmidt‐Glenewinkel, T., & Figueiredo‐Pereira, M. E. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00329.x · Cited by 110
The role of mitochondria in aging of skeletal muscle
Figueiredo, P. A., Mota, M. P., Appell, H. J., & Duarte, J. A. (2008) · Biogerontology · doi:10.1007/s10522-007-9121-7 · Cited by 109 · cited 1×
“Moreover, muscle abilities for removing dysfunctional mitochondria become deficient, perpetuating Os [75, 84, 85].”
BackgroundAbrigo, J., Rivera, J. C., Aravena, J., Cabrera, D., Simon, F., Ezquer, F., Ezquer, M., & Cabello-Verrugio, C. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9047821 · Cited by 109
Self-citationAdaptive thermogenesis can make a difference in the ability of obese individuals to lose body weight
Tremblay, A., Royer, M.-M., Chaput, J.-P., & Doucet, É. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.124 · Cited by 108 · cited 1×
“Also, in aging, there are decreased rest metabolic rates (4% per decade after the age of 50 years), reduced motor neurons, and skeletal muscle metabolic adaptations, which could also favor obesity and loss of muscle mass [14, 31, 37, 73, 74].”
BackgroundLeptin in Sarcopenic Visceral Obesity: Possible Link between Adipocytes and Myocytes
Kohara, K., Ochi, M., Tabara, Y., Nagai, T., Igase, M., & Miki, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024633 · Cited by 99 · cited 1×
“High leptin levels in aging and obesity upregulate the proinflammatory cytokines IL-6 and TNF-α, reducing insulin-like growth factor 1 (IGF1) activity and decreasing their anabolic actions on skeletal muscle [14, 43, 44].”
BackgroundAndrogens and Women at the Menopause and Beyond
Morley, J. E., & Perry, H. M. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.5.m409 · Cited by 98
Qaisar, R., Bhaskaran, S., Premkumar, P., Ranjit, R., Natarajan, K. S., Ahn, B., Riddle, K., Claflin, D. R., Richardson, A., Brooks, S. V., et al. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12339 · Cited by 95
Endoplasmic reticulum stress in human skeletal muscle: any contribution to sarcopenia?
Deldicque, L. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00236 · Cited by 91 · cited 1×
“Furthermore, physical inactivity, a feature typically observed in aging and obesity, favors ER stress and UPR overactivation, inducing Os [93, 102].”
BackgroundSarcopenic obesity: An appraisal of the current status of knowledge and management in elderly people
Molino, S., Dossena, M., Buonocore, D., & Verri, M. (2016) · The Journal of nutrition, health and aging · doi:10.1007/s12603-015-0631-8 · Cited by 91
BAM15‐mediated mitochondrial uncoupling protects against obesity and improves glycemic control
Axelrod, C. L., King, W. T., Davuluri, G., Noland, R. C., Hall, J., Hull, M., Dantas, W. S., Zunica, E. R., Alexopoulos, S. J., Hoehn, K. L., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012088 · Cited by 89 · cited 1×
“Besides, BAM15 improved glycemic control and reduced adiposity through insulin signaling and oxidation of glucose and fatty acids in an AMPK-dependent manner [134].”
BackgroundSarcopenic obesity: satellite cells in the aging muscle
Thornell, L.-E. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283412260 · Cited by 86
Sarcopenic obesity: research advances in pathogenesis and diagnostic criteria
Xie, W.-Q., Xiao, G.-L., Fan, Y.-B., He, M., Lv, S., & Li, Y.-S. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01435-9 · Cited by 86 · cited 12×
“The obesity diagnosis is marked by difficulties, particularly in relation to BMI.”
BackgroundMethodInfluentialCisternas, F., Morales, M. G., Meneses, C., Simon, F., Brandan, E., Abrigo, J., Vazquez, Y., & Cabello-Verrugio, C. (2015) · Clinical Science · doi:10.1042/cs20140215 · Cited by 83
Self-citationLongitudinal changes in dehydroepiandrosterone concentrations in men and women
Nafziger, A. N., Bowlin, S. J., Jenkins, P. L., & Pearson, T. A. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90181-0 · Cited by 82
Rosiglitazone modifies the adipogenic potential of human muscle satellite cells
De Coppi, P., Milan, G., Scarda, A., Boldrin, L., Centobene, C., Piccoli, M., Pozzobon, M., Pilon, C., Pagano, C., Gamba, P., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0304-6 · Cited by 81
An, K. O., & Kim, J. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.07.005 · Cited by 81
Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy via the Mas receptor
Morales, M. G., Abrigo, J., Acuña, M. J., Santos, R. A., Bader, M., Brandan, E., Simon, F., Olguin, H., Cabrera, D., & Cabello-Verrugio, C. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.023390 · Cited by 77
Self-citationRole of the Cytokine-like Hormone Leptin in Muscle-bone Crosstalk with Aging
Hamrick, M. W. (2017) · Journal of Bone Metabolism · doi:10.11005/jbm.2017.24.1.1 · Cited by 77
Cho, Y., Shin, S.-Y., & Shin, M.-J. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.04.002 · Cited by 75 · cited 9×
“The obesity diagnosis is marked by difficulties, particularly in relation to BMI.”
MethodInfluentialThe ER and ageing II: Calcium homeostasis
Puzianowska-Kuznicka, M., & Kuznicki, J. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.05.002 · Cited by 73
Shefer, G., Rauner, G., Stuelsatz, P., Benayahu, D., & Yablonka‐Reuveni, Z. (2013) · The FEBS Journal · doi:10.1111/febs.12228 · Cited by 72 · cited 1×
“Furthermore, aginginduced myosteatosis promotes lipotoxicity (Lptx) and contributes to inflammation [49, 50].”
BackgroundChanges in Redox Signaling in the Skeletal Muscle with Aging
Szentesi, P., Csernoch, L., Dux, L., & Keller-Pintér, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4617801 · Cited by 71 · cited 4×
“In this regard, aging causes the loss of type II muscle fibers more than type I, probably because type II fibers have a low mitochondrial quantity, making them more susceptible to degradation and loss of muscle mass [75, 87, 88].”
BackgroundInfluentialDysfunctional autophagy is a driver of muscle stem cell functional decline with aging
García-Prat, L., Muñoz-Cánoves, P., & Martinez-Vicente, M. (2016) · Autophagy · doi:10.1080/15548627.2016.1143211 · Cited by 70
Body composition, metabolic syndrome and testosterone in ageing men
Allan, C. A., Strauss, B. J. G., & McLachlan, R. I. (2007) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901552 · Cited by 67
Overweight in elderly people induces impaired autophagy in skeletal muscle
Potes, Y., de Luxán-Delgado, B., Rodriguez-González, S., Guimarães, M. R. M., Solano, J. J., Fernández-Fernández, M., Bermúdez, M., Boga, J. A., Vega-Naredo, I., & Coto-Montes, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.05.018 · Cited by 67 · cited 2×
“Thus, Os could play a fundamental role in losing the muscle mass that characterizes SO and promote IR [76, 92, 103].”
BackgroundRivas, E., Arismendi, E., Agustí, A., Sanchez, M., Delgado, S., Gistau, C., Wagner, P. D., & Rodriguez-Roisin, R. (2015) · Chest · doi:10.1378/chest.14-1749 · Cited by 65
Dutra, M. T., Avelar, B. P., Souza, V. C., Bottaro, M., Oliveira, R. J., Nóbrega, O. T., & Moreno Lima, R. (2017) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12287 · Cited by 63
Morales, M. G., Olguín, H., Di Capua, G., Brandan, E., Simon, F., & Cabello-Verrugio, C. (2015) · Clinical Science · doi:10.1042/cs20140840 · Cited by 62
Self-citationMuscle Wasting in Ageing and Chronic Illness
Ebner, N., Sliziuk, V., Scherbakov, N., & Sandek, A. (2015) · ESC Heart Failure · doi:10.1002/ehf2.12033 · Cited by 61 · cited 1×
“In sarcopenia, the loss of muscle mass and strength leads to reductions in physical activity and mobility, inducing Os, exacerbating sarcopenia, and generating an endless circle [107, 108, 110].”
BackgroundAge‐Dependent Effects on Functional Aspects in Human Satellite Cells
BECCAFICO, S., PUGLIELLI, C., PIETRANGELO, T., BELLOMO, R., FANÒ, G., & FULLE, S. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1395.037 · Cited by 61 · cited 1×
“The increased ROS levels and decreased antioxidant activity in satellite cells [121, 122] could dysregulate basal autophagy (essential to maintaining the quiescent state of stem cells) and impair the removal of misfolded proteins, thereby affecting satellite cell homeostasis [87, 116].”
BackgroundYin, Y.-H., Liu, J. Y. W., & Välimäki, M. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110937 · Cited by 61
Favorable Vascular Actions of Angiotensin-(1–7) in Human Obesity
Schinzari, F., Tesauro, M., Veneziani, A., Mores, N., Di Daniele, N., & Cardillo, C. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10280 · Cited by 57 · cited 1×
“In obese humans, Ang-(1-7) administration decreased vascular dysfunction related to impaired insulin sensitivity [140].”
BackgroundSarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
Nishikawa, H., Enomoto, H., Nishiguchi, S., & Iijima, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041917 · Cited by 56 · cited 2×
“As mentioned earlier, physical inactivity and obesity increase the level of lipid circulation and myosteatosis in skeletal muscle, contributing to a decrease in muscle mass and strength and favoring sarcopenia and physical disabilities [14, 22, 66].”
BackgroundLow muscle mass in older men: The role of lifestyle, diet and cardiovascular risk factors
Atkins, J. L., Whincup, P. H., Morris, R. W., & Wannamethee, S. G. (2014) · The Journal of nutrition, health and aging · doi:10.1007/s12603-013-0336-9 · Cited by 55 · cited 1×
“High leptin levels in aging and obesity upregulate the proinflammatory cytokines IL-6 and TNF-α, reducing insulin-like growth factor 1 (IGF1) activity and decreasing their anabolic actions on skeletal muscle [14, 43, 44].”
BackgroundIndividualizing recommendations for weight management in the elderly
Chau, D., Cho, L. M., Jani, P., & St. Jeor, S. T. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3282f31744 · Cited by 52 · cited 1×
“Also, in aging, there are decreased rest metabolic rates (4% per decade after the age of 50 years), reduced motor neurons, and skeletal muscle metabolic adaptations, which could also favor obesity and loss of muscle mass [14, 31, 37, 73, 74].”
BackgroundPurcell, S. A., Mackenzie, M., Barbosa-Silva, T. G., Dionne, I. J., Ghosh, S., Siervo, M., Ye, M., & Prado, C. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.583825 · Cited by 48 · cited 1×
“Similarly, there is a need for advances in reaching a consensus in the methodology for the SO diagnosis that can be applicable in different populations, ideally used in clinical practice, and feasible for use in long-standing studies [3, 7, 12, 16, 37, 48, 152, 153].”
BackgroundSarcopenia in nonalcoholic fatty liver disease: new challenges for clinical practice
Sherif, O. E., Dhaliwal, A., Newsome, P. N., & Armstrong, M. J. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1731303 · Cited by 46
Yin, T., Zhang, J.-X., Wang, F.-X., Zhao, J.-H., Zhao, Y., Liu, L., Liu, X.-Y., Zhang, Y.-H., & Zhao, Y. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s308387 · Cited by 44
Pathways to Severe COVID‐19 for People with Obesity
O’Rourke, R. W., & Lumeng, C. N. (2021) · Obesity · doi:10.1002/oby.23099 · Cited by 42
Tallis, J., Shelley, S., Degens, H., & Hill, C. (2021) · Biomolecules · doi:10.3390/biom11030372 · Cited by 41
Zwetsloot, K. A., Childs, T. E., Gilpin, L. T., & Booth, F. W. (2013) · Cell Proliferation · doi:10.1111/cpr.12007 · Cited by 35 · cited 1×
“Furthermore, aginginduced myosteatosis promotes lipotoxicity (Lptx) and contributes to inflammation [49, 50].”
BackgroundÁbrigo, J., Simon, F., Cabrera, D., & Cabello-Verrugio, C. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452522 · Cited by 35
Self-citationAging, metabolism and stem cells: Spotlight on muscle stem cells
García-Prat, L., & Muñoz-Cánoves, P. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.021 · Cited by 34 · cited 2×
“The increased ROS levels and decreased antioxidant activity in satellite cells [121, 122] could dysregulate basal autophagy (essential to maintaining the quiescent state of stem cells) and impair the removal of misfolded proteins, thereby affecting satellite cell homeostasis [87, 116].”
BackgroundM. Carrascosa, J., Andres, A., Ros, M., Bogonez, E., Arribas, C., Fernandez-Agullo, T., J. De Solis, A., Gallardo, N., & Martinez, C. (2011) · Current Protein & Peptide Science · doi:10.2174/138920311795906655 · Cited by 33 · cited 2×
“The WHO recognizes obesity as a chronic and progressive disease with a high chance of relapse, so it is considered a world epidemic [33].”
BackgroundSytze van Dam, P., Smid, H. E. C., de Vries, W. R., Niesink, M., Bolscher, E., Waasdorp, E. J., Dieguez, C., Casanueva, F. F., & Koppeschaar, H. P. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7087 · Cited by 32
Master Regulators of Muscle Atrophy: Role of Costamere Components
Gorza, L., Sorge, M., Seclì, L., & Brancaccio, M. (2021) · Cells · doi:10.3390/cells10010061 · Cited by 31 · cited 1×
“Another redox-sensitive transcription factor is nuclear factor kappa B (NF-κB), which dramatically increases muscle activity in sarcopenia, metabolic syndrome, and obesity [83, 113].”
BackgroundLoloi, J., Miller, A. J., Bingaman, S. S., Silberman, Y., & Arnold, A. C. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00281.2018 · Cited by 30 · cited 1×
“The administration of Ang-(1-7) to mice with obesity or metabolic syndrome reduced body weight, upregulated thermogenesis and brown adipose tissue (BAT), and ameliorated impaired glucose [138].”
BackgroundChung, E., Campise, S. N., Joiner, H. E., Tomison, M. D., Kaur, G., Dufour, J. M., Cole, L., Ramalingam, L., Moustaid-Moussa, N., & Shen, C.-L. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.021 · Cited by 26
Minet, A. D., & Gaster, M. (2012) · Biogerontology · doi:10.1007/s10522-012-9372-9 · Cited by 25 · cited 1×
“The increased ROS levels and decreased antioxidant activity in satellite cells [121, 122] could dysregulate basal autophagy (essential to maintaining the quiescent state of stem cells) and impair the removal of misfolded proteins, thereby affecting satellite cell homeostasis [87, 116].”
BackgroundLinking epidemiology and molecular mechanisms in sarcopenic obesity in populations
El Bizri, I., & Batsis, J. A. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120000075 · Cited by 23 · cited 1×
“Similarly, there is a need for advances in reaching a consensus in the methodology for the SO diagnosis that can be applicable in different populations, ideally used in clinical practice, and feasible for use in long-standing studies [3, 7, 12, 16, 37, 48, 152, 153].”
BackgroundGutiérrez-López, L., Olivares-Corichi, I. M., Martínez-Arellanes, L. Y., Mejía-Muñoz, E., Polanco-Fierro, J. A., & García-Sánchez, J. R. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111360 · Cited by 23 · cited 1×
“Interestingly, a recent study showed that a moderate-intensity exercise program reduces oxidative damage and increases the antioxidant system, thereby serving as a feasible tool for treating SO [151].”
BackgroundBorg, M. L., Massart, J., De Castro Barbosa, T., Archilla‐Ortega, A., Smith, J. A. B., Lanner, J. T., Alsina‐Fernandez, J., Yaden, B., Culver, A. E., Karlsson, H. K. R., et al. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12746 · Cited by 23
Association between Obesity and Unintentional Injury in Older Adults
Bouchard, D. R., Pickett, W., & Janssen, I. (2010) · Obesity Facts · doi:10.1159/000322873 · Cited by 22
Pain Characteristics and Quality of Life in Older People at High Risk of Future Hospitalization
Johansson, M. M., Barbero, M., Peolsson, A., Falla, D., Cescon, C., Folli, A., & Dong, H.-J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18030958 · Cited by 18
Yoshikawa, M., Hosokawa, M., Miyashita, K., Fujita, T., Nishino, H., & Hashimoto, T. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05369-8 · Cited by 15 · cited 1×
“Interestingly, the effects of FXOH were dependent on Os [136].”
BackgroundResistance Training Reduces Risk of Sarcopenia in Patients With Cirrhosis
Tandon, P., Dunn, M. A., & Duarte‐Rojo, A. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.09.030 · Cited by 11 · cited 1×
“According to the European Working Group on Sarcopenia in Older People (EWGSOP), the diagnosis of sarcopenia is based on the presence of three criteria: (i) loss of muscle strength (a leading indicator of sarcopenia), (ii) decrease in the quantity or quality of muscle mass, and (iii) low physical performance [23, 26, 2…”
BackgroundAlves Guimarães, M. S., Araújo dos Santos, C., da Silva Castro, J., Juvanhol, L. L., Canaan Rezende, F. A., Martinho, K. O., & Ribeiro, A. Q. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.11.004 · Cited by 10 · cited 3×
“These methodologies are also a challenge to perform large-scale research and compare data between studies [19].”
BackgroundBarbosa, M. A., de Sousa, G. G., de Castro, U. G. M., Carneiro, C. M., Figueiredo, V. P., Guerra de Sá, R., Santos, R. A. S. D., & Alzamora, A. C. (2019) · Nutrition · doi:10.1016/j.nutx.2019.100004 · Cited by 9 · cited 1×
“In obese rats, Ang-(1–7) enhanced glucose tolerance, insulin sensitivity, and decreased plasma insulin levels, as well as a significant decrease in circulating lipid levels [139].”
BackgroundNakano, R., Takebe, N., Ono, M., Hangai, M., Nakagawa, R., Yashiro, S., Murai, T., Nagasawa, K., Takahashi, Y., Satoh, J., et al. (2017) · Obesity Science & Practice · doi:10.1002/osp4.97 · Cited by 8 · cited 5×
“People that develop SO are primarily over 60 years old, with comorbidities such as type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver diseases (NAFLD), dyslipidemia, hypertension, and cardiovascular disease.”
BackgroundInfluentialPereyra, A. S., Wang, Z.-M., Messi, M. L., Zhang, T., Wu, H., Register, T. C., Forbes, E., Devarie‐Baez, N. O., Files, D. C., Abba, M. C., et al. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw192 · Cited by 7 · cited 2×
“In skeletal muscle, BDA-410 improved the skeletal muscle contractility by mechanisms dependent on enhanced lipolysis and excitation-contraction coupling, favoring a lean phenotype [135].”
BackgroundRossi, A. P., Rubele, S., & Zamboni, M. (2019) · Nutrition and Skeletal Muscle · doi:10.1016/b978-0-12-810422-4.00006-3 · Cited by 5 · cited 5×
“Also, in aging, there are decreased rest metabolic rates (4% per decade after the age of 50 years), reduced motor neurons, and skeletal muscle metabolic adaptations, which could also favor obesity and loss of muscle mass [14, 31, 37, 73, 74].”
BackgroundInfluential
Cited by
Sarcopenic obesity in older adults: a clinical overview
Prado, C. M., Batsis, J. A., Donini, L. M., Gonzalez, M. C., & Siervo, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00943-z · Cited by 355
“…mental stress), age-related changes in body composition 47 , hormonal imbalances 48 , declining neuromuscular function 49 , increased inflammation and oxidative stress 50 , reduced activity of muscle satellite cells 51 , altered energy metabolism, and impaired metabolic–vascular coupling 52 (Fig.”
Oxidative stress: Roles in skeletal muscle atrophy
Zhang, H., Qi, G., Wang, K., Yang, J., Shen, Y., Yang, X., Chen, X., Yao, X., Gu, X., Qi, L., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115664 · Cited by 301
Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
Wei, S., Nguyen, T. T., Zhang, Y., Ryu, D., & Gariani, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1185221 · Cited by 291
“Oxidative stress can also lead to ER stress, which is characterized by unfolded protein response (UPR) causing dysfunction of proteasomal degradation and autophagy, which reduces protein levels and causes an imbalance in calcium homeostasis that altogether favor a decrease in muscle mass (30, 31).”
BackgroundVascular Impairment, Muscle Atrophy, and Cognitive Decline: Critical Age-Related Conditions
de Lima, E. P., Tanaka, M., Lamas, C. B., Quesada, K., Detregiachi, C. R. P., Araújo, A. C., Guiguer, E. L., Catharin, V. M. C. S., de Castro, M. V. M., Junior, E. B., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12092096 · Cited by 73
Sarcopenia and nervous system disorders
Yang, J., Jiang, F., Yang, M. J., & Chen, Z. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11268-8 · Cited by 85
“Oxidative stress has been linked to sarcopenia [77] and cognitive impairment [78], according to research.”
Metadata
- Authors
- Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C.
- Affiliations
- Pontificia Universidad Católica de Valparaíso (CL)
- Pontificia Universidad Católica de Chile (CL)
- ORCID
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2021-01
- Volume
- 2021
- Issue
- 1
- Pages
- 4493817-4493817
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC8526202
- OpenAlex
- W3205252850
- Cited by
- 79
- References
- 160
- Citations by year
- 2026: 20 · 2025: 25 · 2024: 14 · 2023: 17 · 2022: 3
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Funders
- CEDENNA (AFB180001, P09-016-F, 1211879, 1201147, 1201039, 1200944)
- Millennium Institute on Immunology and Immunotherapy (AFB180001, P09-016-F, 1211879, 1201147, 1201039, 1200944)
- National Fund for Science and Technological Development (AFB180001, P09-016-F, 1211879, 1201147, 1201039, 1200944)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Exercise and Physiological Responses
- Keywords
- sarcopenic obesity, oxidative stress, sarcopenia, obesity, muscle mass, muscle strength, insulin resistance, inflammatory cytokines, satellite cells, mitochondrial dysfunction, endoplasmic reticulum stress, metabolic syndrome, aging, physical activity
- MeSH terms
- Humans, Middle Aged, Obesity, Oxidative Stress, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.